Veeva
Veeva is a life sciences cloud software and data platform provider.
Analyst Perspective
Veeva Systems Inc. is a public B2B software company that builds cloud applications and data products for the life sciences sector. Its product estate spans regulated content management, clinical operations, development, quality, safety, medical affairs, CRM, and commercial data, with a common platform architecture designed for pharmaceutical, biotech, and related regulated organisations. The company primarily generates revenue from recurring enterprise software subscriptions, with additional monetisation from data subscriptions, modular product licensing, and selective usage-based pricing for newer capabilities. Its customers are mainly large life sciences enterprises and their functional teams across R&D, regulatory, quality, medical, commercial, and clinical operations.
Analyst Signal Briefing
Updated: 13 Aug 2026Veeva continues to expand its AI-driven automation capabilities following the acquisition of Copli and the launch of Veeva Falcon MLR for accelerated content review. The company recently secured a significant global deployment of Vault CRM with Eli Lilly, supporting an "agentic commercial" model that integrates AI across life sciences workflows. These developments, complemented by Anthill Cloud’s new US integrations and ongoing Crossix optimisation within PulsePoint, reinforce Veeva’s strategy of embedding compliance-ready tools into foundational systems to drive operational adoption and long-term customer retention.
Explorer Tier
Start exploring for free
Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.
- View public Company Profiles
- Save/watch companies
- Build your first Watchlist
- Access additional market signals
Key insights about Veeva
Category Differentiation
Veeva is not a general consumer app or horizontal marketing platform. It is a sector-specific enterprise software and data provider focused on regulated life sciences workflows.
Veeva: About
Veeva operates a vertical enterprise software model focused on regulated life sciences workflows. It creates value by offering a sector-specific cloud platform and adjacent applications that replace fragmented legacy systems, support compliance requirements, centralise content and operational data, and connect multiple functions across the product lifecycle. Revenue expands through module adoption, platform standardisation, multi-year enterprise contracts, and attached data products.
How Veeva Works & Monetises
Business model analysis and core revenue streams
The company mainly uses recurring enterprise SaaS subscriptions priced by product suite, user counts, and deployment scope. It also monetises proprietary data products through subscription licensing, supports tiered product packaging across CRM and platform modules, and has introduced usage-based charging for some newer AI-driven capabilities. Commercial upside comes from cross-selling additional clouds, data assets, and acquired capabilities into existing enterprise accounts.
Revenue Channels
Side-by-Side Comparisons
Compare Veeva directly with top competitors
Products & Services in Categories
Verified structural categorizations from the graph
Veeva: Key Competitors & Alternatives
- Analyze Profile →
Enterprise SaaS platform for CRM, marketing, data, analytics, and workflows.
- Analyze Profile →
Enterprise cloud infrastructure and customer experience software provider.
Recent Signals (Veeva)
Eli Lilly Selects Veeva Vault CRM Globally
Veeva Systems announced that Eli Lilly and Company has committed to Veeva Vault CRM for global deployment. Vault CRM, part of Veeva's Vault CRM Suite, is described as the technology foundation for “agentic commercial,” a commercial model that leverages AI to deliver medicines to patients. Giuseppe Firenze, senior vice president, U.S. HCP and field engagement hub at Lilly, and Veeva CEO Peter Gassner are quoted on the strategic expansion. Veeva is described as an industry cloud provider for life sciences serving more than 1,500 customers and operating as a Public Benefit Corporation. The announcement was distributed via PR Newswire and published on MarTech Series on August 11, 2026.
Read original sourceThree non-AI martech shifts to watch
The article argues that while AI dominates martech conversations, three important, largely non-AI trends deserve attention: stack rationalization and core tool governance as organizations reduce software bloat and enforce governance; a resurgence of marketing mix modeling paired with continuous incrementality testing to measure channel impact using aggregate, privacy-safe data; and adoption of modular content architecture/atomic design systems stored in headless CMSs to scale creative production across channels. The piece emphasizes operational maturity, optimizing existing foundational systems, and practical architectures over chasing every new tool.
Read original sourceVeeva Acquires Copli, Launches Veeva Falcon MLR to Accelerate Content Review
Veeva Acquires Copli, Launches Veeva Falcon MLR to Accelerate Content Review
Read original sourceVeeva: Frequently Asked Questions
What is Veeva?
Veeva is a public enterprise software company providing cloud applications and data products for life sciences organisations.
Who uses Veeva?
Its users are mainly pharmaceutical, biotech, CRO, regulatory, quality, safety, medical, clinical, and commercial teams inside large life sciences organisations.
How does Veeva make money?
Veeva earns revenue mainly from recurring SaaS subscriptions, plus data subscriptions, modular licensing, and some usage-based fees for newer capabilities.
Company Facts
- Founded
- 2007
- Headquarters
- United States
- Core Segment
- B2B SaaS Provider
- Company Size
- >5,000
- Official Link
- veeva.com